These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Gemfibrozil: new aspects in clinical use]. Tada N Nihon Rinsho; 2001 Mar; 59 Suppl 3():625-30. PubMed ID: 11347143 [No Abstract] [Full Text] [Related]
11. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease? Ahmed MH J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):858-60. PubMed ID: 20686417 [TBL] [Abstract][Full Text] [Related]
12. The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia. Stewart MW; Dyer RG; Alberti KG; Laker MF Diabet Med; 1995 Mar; 12(3):250-7. PubMed ID: 7758262 [TBL] [Abstract][Full Text] [Related]
13. Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes. Wägner AM; Ordóñez-Llanos J; Jorba O; Pérez A Metabolism; 2004 Nov; 53(11):1516. PubMed ID: 15558848 [No Abstract] [Full Text] [Related]
14. Normocholesterolaemic dyslipidaemia: is there a role for fibrates? Tallis GA Med J Aust; 2001 Jun; 174(11):610; author reply 611. PubMed ID: 11453340 [No Abstract] [Full Text] [Related]
15. Dual bezafibrate-simvastatin therapy for combined hyperlipidaemia. Hutchesson AC; Moran A; Jones AF J Clin Pharm Ther; 1994 Dec; 19(6):387-9. PubMed ID: 7876371 [TBL] [Abstract][Full Text] [Related]
18. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group. Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751 [TBL] [Abstract][Full Text] [Related]
19. Using lipid-lowering agents effectively. When diet is not enough. Scott D; Kurenitz M Postgrad Med; 1990 Jun; 87(8):171-6, 179-81, 186. PubMed ID: 2189126 [TBL] [Abstract][Full Text] [Related]
20. Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism. Liberopoulos E; Miltiadous G; Elisaf M Diabetes Obes Metab; 2001 Apr; 3(2):97-8. PubMed ID: 11298731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]